Promising new eye treatment could halt vision loss from keratoconus

NCT ID NCT06100952

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 3 trial tested a new type of corneal cross-linking that does not require removing the surface layer of the eye. It involved 398 people aged 8 to 45 with keratoconus, a condition that thins and bulges the cornea. The treatment uses riboflavin eye drops and ultraviolet light to strengthen the cornea and stop the disease from progressing.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Riboflavin and sodium iodide eye drops plus ultraviolet-A light treatment
What this could lead to
If successful, this could offer a less painful, faster-recovery treatment to stop keratoconus from getting worse and improve vision.
What could go wrong
This is a phase 3 trial, but results are not yet published. The treatment may not work better than a sham procedure, and there are risks like infection or corneal scarring.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KERATOCONUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Catalina Eye Center

    Tucson, Arizona, 85712, United States

  • Chicago Cornea Consultants

    Highland Park, Illinois, 60035, United States

  • Claris Vision LLC Eye Health Vision Centers - Dartmouth

    North Dartmouth, Massachusetts, 02747, United States

  • Dell Laser Consultants

    Austin, Texas, 78746, United States

  • Hoopes Vision

    Draper, Utah, 84020, United States

  • Inland Eye Specialists

    Murrieta, California, 92562, United States

  • Providence Eye and Laser Specialists

    Charlotte, North Carolina, 28226, United States

  • Schwartz Laser Eye Center

    Scottsdale, Arizona, 85260, United States

  • Truhlsen Eye Institute

    Omaha, Nebraska, 68105, United States

  • University of Colorado

    Aurora, Colorado, 80045, United States

  • VRF Eye Specialty Group

    Memphis, Tennessee, 38120, United States

  • Virginia Eye Consultants

    Norfolk, Virginia, 23502, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.